Related Experiment Videos
A dedicated team approach enhances outcomes of osteomyelitis treatment
Bruce H Ziran1, Nalini Rao, Ronald A Hall
1Department of Orthopaedic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Abstract:
To assess the impact of a dedicated musculoskeletal infection team, 70 musculoskeletal infections (traumatic and non-traumatic chronic osteomyelitis, Cierny-Mader Type III or IV) in 58 patients with were treated in two groups. Group I (43 infections) was treated with the assistance of an on-call infectious disease specialist. Group II (27 infections) was treated with the assistance of a dedicated musculoskeletal infectious disease specialist. Overall, there was a 42% success in Group I compared with 78% success in Group II. When stratified by infection type, in patients with Type III infections, there was a 56% success in Group I and a 90% success rate in Group II. For patients with Type IV infections, there was a 25% success rate in Group I and a 71% success rate in Group II. The participation of the dedicated musculoskeletal infectious disease specialist significantly improved patient outcomes.
Insights
A dedicated musculoskeletal infection team significantly improved treatment success rates for chronic osteomyelitis. Patients treated with a specialized team saw higher success compared to those with general infectious disease consultation.
Area of Science:
- Orthopedics
- Infectious Diseases
- Medical Team Management
Background:
- Musculoskeletal infections, including chronic osteomyelitis (Cierny-Mader Type III or IV), present complex treatment challenges.
- Effective management requires specialized knowledge in both orthopedic and infectious disease domains.
Purpose of the Study:
- To evaluate the impact of a dedicated musculoskeletal infection team on treatment outcomes.
- To compare the efficacy of a specialized team versus on-call infectious disease consultation for complex musculoskeletal infections.
Main Methods:
- Retrospective analysis of 70 musculoskeletal infections in 58 patients.
- Patients were divided into two groups: Group I (on-call infectious disease specialist) and Group II (dedicated musculoskeletal infectious disease specialist).
- Outcomes were assessed based on infection type (Cierny-Mader Type III and IV) and overall success rates.
Main Results:
- Overall success rates were 42% in Group I versus 78% in Group II.
- For Type III infections, success rates were 56% (Group I) and 90% (Group II).
- For Type IV infections, success rates were 25% (Group I) and 71% (Group II).
Conclusions:
- The involvement of a dedicated musculoskeletal infectious disease specialist significantly enhances treatment success for chronic osteomyelitis.
- Specialized multidisciplinary teams improve outcomes for complex orthopedic infections.